Clinical and molecular analyses of NEONAB: a phase II trial of breast cancer patients treated with neoadjuvant epirubicin, cyclophosphamide and nab-paclitaxel

Murphy, C

Clinical and molecular analyses of NEONAB: a phase II trial of breast cancer patients treated with neoadjuvant epirubicin, cyclophosphamide and nab-paclitaxel

https://hdl.handle.net/10536/DRO/DU:30132847
Open external identifier URL

thesis

posted on 2018-08-01, 00:00 authored by C Murphy

This thesis presents the clinical, imaging and translational research outcomes from NEONAB: a phase II clinical trial in early breast cancer.

History

Open access

Yes

Material type

thesis

Resource type

thesis

Language

eng

Copyright notice

The author

Editor/Contributor(s)

S McGee, M Khasraw, D Ashley

Pagination

117 p.

Degree type

Research masters

Degree name

M.App.Sc. (Medicine)

Thesis faculty

Faculty of Health

Thesis school

School of Medicine

Usage metrics

Keywords

untagged Molecular Targets Cancer Genetics Chemotherapy

Clinical and molecular analyses of NEONAB: a phase II trial of breast cancer patients treated with neoadjuvant epirubicin, cyclophosphamide and nab-paclitaxel

History

Open access

Material type

Resource type

Language

Copyright notice

Editor/Contributor(s)

Pagination

Degree type

Degree name

Thesis faculty

Thesis school

Usage metrics

Categories

Keywords

Licence

Exports